Recently it has been observed that UbcH10 is highly expressed in Bortezomib (BTZ)-resistant myeloma cell lines U-266/BTZ, NCI-H929/BTZ and RPMI-8226/BTZ evaluated in a gradient of BTZ increasing concentrations. This evidence concerns the gene UBE2C and plasma cell myeloma.